A panel of the Inquiry Committee approved a Consent Agreement under which the Registrant agreed to undertakings involving regular monitoring for fitness to practice nursing. The undertakings include, but are not limited to: robust medical monitoring, including the commitment to abstain from mind-altering substances including habit-forming prescriptions through the signing a Relapse Prevention Agreement that will remain in effect for at least 36 consecutive months of documented compliance. The later will be overseen by an independent, professional monitor who will review the Registrant's attendance of at least three abstinence-based mutual support meetings per week. The Registrant will provide random biological samples for drug and alcohol (EtG) testing at least twice a month. The Agreement will remain in place for a minimum of 36 months of continuous nursing practice. The reasons for the Inquiry Committee decision are as follows:
- The Registrant provided an independent medical assessment documenting health concerns to BCCNP which could impact the ability to provide safe patient care; and
- The independent medical assessment identified the Registrant is fit to practice nursing, and provided information regarding compliance with treatment recommendations.
The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the
Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition.
The Inquiry Committee is satisfied that the undertakings will protect the public.